TD Cowen lowered the firm’s price target on P3 Health Partners (PIII) to 25c from 90c and keeps a Hold rating on the shares. The firm updated its model to reflect 3Q24 results. The model assumes the company requires a $100m capital raise in 2025 to support continued operating losses.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio